Wei Li also explains why investing in investment grade credit is a ‘straightforward’ call right now.
Author Archives: Thomas Blott
Originally from the UK, Thomas is a financial journalist with over 10 years’ experience including nine in Asia. He began his career at Euromoney Institutional Investor, completing the graduate scheme and going on to establish the Asia bureau for IJGlobal, the world’s foremost source of intelligence on the project finance market. After a stint at KPMG, he joined International Financing Review, which was originally owned by Thomson Reuters and later Refinitiv, where he managed the people & markets section in Asia. He joined Bonhill Group as regional editor for Asia in 2022, which includes oversight of Fund Selector Asia. He is a graduate of the University of Cambridge. Connect with him on LinkedIn here.
Inflows to Japan reach highest level this year
According to Morningstar Direct data, inflows to Japan funds in July hit their highest level since December.
Syfe launches DPM in Hong Kong
The Singapore-based digital wealth platform has onboarded funds from AllianceBernstein, HSBC and Franklin Templeton.
Endowus raises $35m in latest funding round
The Singapore-headquartered digital wealth adviser tapped Citi Ventures and MUFG Innovation Partners for funding.
Fullerton launches Indonesian firm with Stockbit
Fullerton had earlier signed a strategic partnership with Indonesia’s Stockbit.
Franklin Templeton opens contact office in Korea
Franklin Templeton announced plans to open the contact office in January.
ETF inflows in Asia hit $29.73bn in 1H 2023
Overall ETF inflows in Asia came in at $29.73bn despite a mixed market backdrop.
JP Morgan AM’s Goldfeld makes the case for high yield
JP Morgan Asset Management’s Leon Goldfeld makes the case for high yield.
Vontobel expands client coverage to Korea
Yong Duk Kim has joined as country head from PGIM Fixed Income.
Indosuez to acquire majority stake in Degroof Petercam
Indosuez Wealth Management will complete the acquisition next year, subject to regulatory approval.
